Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

Discover how a common rash could be a sign of rosacea, a chronic condition affecting millions, and what new treatments can ...

Painful skin and trouble sleeping are among the problems reported when tapering cortisone cream for atopic eczema. This has ...

Long-term secukinumab treatment among patients with hidradenitis suppurativa did not meet the time to loss of response endpoint at 104 weeks.